ARIAD (ARIA) Briefing Documents Posted
Tweet
Share
E-mailGet Alerts ARIA Hot Sheet
Join SI Premium – FREE
ARIAD Pharmaceuticals (Nasdaq: ARIA) FDA briefing documents posted ahead of March 20 FDA AdCom meeting. Link
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA authorizes 11 ZYN Ultra nicotine pouches for Philip Morris
- FTC files amicus brief challenging Amgen's Enbrel patent acquisition
- SEC accuses ex-BofA senior banker Satsky of insider trading - Bloomberg
Create E-mail Alert Related Categories
FDA, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
